Latisse Rx Only

$179.00

Longer, Thicker, Darker Lashes with LATISSE®.

LATISSE is an FDA-approved treatment to grow eyelashes for people with inadequate or not enough lashes.

  • 5mL
  • Please note: a prescription is required to purchase this product. Please enter the Name and Account No of the prescription holder.

Category: Filter Productss: ,

Description

There’s been a growing interest in this product ever since it was introduced. And it’s no wonder. LATISSE is the first FDA-approved prescription treatment for inadequate or not enough eyelashes, growing them longer, fuller and darker.

Discover the LATISSE difference.

LATISSE solution is a growth treatment for hypotrichosis (inadequate or not enough eyelashes). In fact, it’s the first FDA-approved treatment clinically proven to grow lashes. And it’s the first lash growth product of its kind available by prescription. So you’ll need to talk to your doctor to see if it’s right for you.

LATISSE grows lashes longer, fuller and darker.

LATISSE solution is a once-nightly treatment you apply topically to the base of your upper eyelashes, as instructed by your doctor. Then, gradually, the results come in. You may start to see more length in as little as 4 weeks and you should achieve full growth in 16 weeks. It’s not an illusion of growth. It’s real lash growth.

How LATISSE works.

LATISSE makes lash growth possible because of its active ingredient: bimatoprost. Although the precise mechanism of action is unknown, LATISSE is believed to affect the growth (anagen) phase of the eyelash hair cycle in two ways: first, it increases the length of this phase, and second, it increases the number of hairs in this growth phase.

The history behind LATISSE.

LATISSE was created by Allergan. In 2001, Allergan developed a medicated eye drop to treat elevated intraocular pressure. Many patients using this medication also began to grow longer, fuller and darker lashes as a side effect. This led Allergan to study the medication’s active ingredient, bimatoprost, specifically for growing lashes. After a clinical trial, LATISSE was approved by the FDA in December of 2008.